ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Benchmark Vaccines Limited

Benchmark Vaccines Limited is a dissolved company incorporated on 4 May 2012 with the registered office located in Worthing, West Sussex. Benchmark Vaccines Limited was registered 13 years ago.
Status
Dissolved
Dissolved on 25 March 2025 (5 months ago)
Was 12 years old at the time of dissolution
Via voluntary strike-off
Company No
08058891
Private limited company
Age
13 years
Incorporated 4 May 2012
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 5 December 2024 (9 months ago)
Next confirmation dated 1 January 1970
Last change occurred 8 years ago
Accounts
Not Submitted
Awaiting first accounts
Contact
Address
Highdown House
Yeoman Way
Worthing
West Sussex
BN99 3HH
United Kingdom
Address changed on 14 Nov 2022 (2 years 9 months ago)
Previous address was Benchmark House 8 Smithy Wood Drive Sheffield S35 1QN
Telephone
01142409939
Email
Unreported
Website
Unreported
People
Officers
3
Shareholders
1
Controllers (PSC)
1
Director • Irish • Lives in UK • Born in May 1977
Director • Chief Executive Officer • Norwegian • Lives in Norway • Born in Oct 1963
Benchmark Animal Health Group Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Benchmark Animal Health Group Limited
Septima Maguire and Prism Cosec Limited are mutual people.
Active
Benchmark Genetics Limited
Prism Cosec Limited and Septima Maguire are mutual people.
Active
Delta Limited
Prism Cosec Limited is a mutual person.
Active
Bibby Line Group Limited
Septima Maguire is a mutual person.
Active
00084968 Limited
Prism Cosec Limited is a mutual person.
Active
Mpac Group Plc
Prism Cosec Limited is a mutual person.
Active
SR Technics UK Limited
Prism Cosec Limited is a mutual person.
Active
Nichols Plc
Prism Cosec Limited is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2014–2023)
Period Ended
30 Sep 2023
For period 30 Sep30 Sep 2023
Traded for 12 months
Cash in Bank
£1K
Decreased by £11K (-92%)
Turnover
Unreported
Same as previous period
Employees
2
Same as previous period
Total Assets
£224K
Decreased by £27K (-11%)
Total Liabilities
-£21.3M
Decreased by £10K (-0%)
Net Assets
-£21.08M
Decreased by £17K (0%)
Debt Ratio (%)
9509%
Increased by 1018.94% (+12%)
Latest Activity
Voluntarily Dissolution
5 Months Ago on 25 Mar 2025
Voluntary Gazette Notice
8 Months Ago on 7 Jan 2025
Application To Strike Off
8 Months Ago on 27 Dec 2024
Confirmation Submitted
9 Months Ago on 10 Dec 2024
Full Accounts Submitted
1 Year 3 Months Ago on 16 May 2024
Confirmation Submitted
1 Year 9 Months Ago on 5 Dec 2023
Full Accounts Submitted
2 Years 2 Months Ago on 6 Jul 2023
Mr Trond Williksen Appointed
2 Years 2 Months Ago on 30 Jun 2023
John William Marshall Resigned
2 Years 2 Months Ago on 30 Jun 2023
Confirmation Submitted
2 Years 9 Months Ago on 5 Dec 2022
Get Credit Report
Discover Benchmark Vaccines Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Final Gazette dissolved via voluntary strike-off
Submitted on 25 Mar 2025
First Gazette notice for voluntary strike-off
Submitted on 7 Jan 2025
Application to strike the company off the register
Submitted on 27 Dec 2024
Confirmation statement made on 5 December 2024 with no updates
Submitted on 10 Dec 2024
Full accounts made up to 30 September 2023
Submitted on 16 May 2024
Confirmation statement made on 5 December 2023 with no updates
Submitted on 5 Dec 2023
Full accounts made up to 30 September 2022
Submitted on 6 Jul 2023
Termination of appointment of John William Marshall as a director on 30 June 2023
Submitted on 30 Jun 2023
Appointment of Mr Trond Williksen as a director on 30 June 2023
Submitted on 30 Jun 2023
Confirmation statement made on 5 December 2022 with no updates
Submitted on 5 Dec 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year